Skip to content

Drug interactions

Apalutamide + Sofosbuvir-velpatasvir-voxilaprevir

Severity: Major

Apalutamide and Sofosbuvir-velpatasvir-voxilaprevir: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Apalutamide is a strong CYP3A4 inducer and also induces P-gp, which can substantially reduce exposure to velpatasvir, voxilaprevir and sofosbuvir. This risks virologic failure.

What this interaction means in plain words

Apalutamide and Sofosbuvir-velpatasvir-voxilaprevir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Apalutamide belongs to Endocrine; Sofosbuvir-velpatasvir-voxilaprevir belongs to Anti Virals.

Evidence level: Moderate

Why it happens

Apalutamide induces CYP3A4 and P-gp, increasing metabolism and efflux of the antiviral components.

What to do

Avoid the combination; defer HCV therapy or pick an alternative anticancer therapy if possible. If unavoidable, monitor HCV RNA and seek specialist advice.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Apalutamide and Sofosbuvir-velpatasvir-voxilaprevir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Apalutamide with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates the interaction as major. Apalutamide and Sofosbuvir-velpatasvir-voxilaprevir can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Apalutamide is a strong CYP3A4 inducer and also induces P-gp, which can substantially reduce exposure to velpatasvir, voxilaprevir and sofosbuvir. This risks virologic failure.

How serious is the interaction between Apalutamide and Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination; defer HCV therapy or pick an alternative anticancer therapy if possible. If unavoidable, monitor HCV RNA and seek specialist advice.

What other medicines interact with Sofosbuvir-velpatasvir-voxilaprevir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir-voxilaprevir with, for example, Fosphenytoin, Phenobarbital, Phenytoin. The full list is on the Sofosbuvir-velpatasvir-voxilaprevir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in